

Lucent Drugs Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 6.28 Cr
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.44 Cr
- Revenue Growth -8.35%
- Profit Growth -29.85%
- Ebitda -18.85%
- Net Worth 52.01%
- Total Assets 49.29%
About Lucent Drugs
Lucent Drugs Private Limited (LDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2017 (Seven years and seven months 16 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 6.28 Cr.
The company currently has active open charges totaling ₹35.44 Cr.
Sreenivasulu Devarasetty and Mahaveer Jain serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100TG2017PTC118662
- Company No.
118662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lucent Drugs?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sreenivasulu Devarasetty ![]() | Director | 02-Aug-2017 | Current |
Mahaveer Jain ![]() | Director | 14-Jun-2022 | Current |
Financial Performance of Lucent Drugs.
Lucent Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.35% decrease. The company also saw a substantial fall in profitability, with a 29.85% decrease in profit. The company's net worth Soared by an impressive increase of 52.01%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lucent Drugs?
In 2023, Lucent Drugs had a promoter holding of 73.63% and a public holding of 26.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Inter Labs (India) Private Limited
Sreenivasulu Devarasetty is a mutual person
- Mentaaz Agritech Private Limited
Sreenivasulu Devarasetty is a mutual person
Charges (Loans)
₹35.44 Cr
₹0
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 18.89 Cr
- State Bank Of India : 16.10 Cr
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
26 Aug 2024 | Standard Chartered Bank | ₹18.89 Cr | Open |
02 Dec 2022 | Hdfc Bank Limited | ₹2.33 M | Open |
21 Oct 2022 | Hdfc Bank Limited | ₹2.21 M | Open |
28 Mar 2018 | State Bank Of India | ₹16.10 Cr | Open |
How Many Employees Work at Lucent Drugs?
Lucent Drugs has a workforce of 63 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lucent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucent Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lucent Drugs
Recent activity within the organization
- Charges
A charge with Standard Chartered Bank amounted to Rs. 18.89 Cr with Charge ID 100986511 was registered on 26 Aug 2024.
- Annual General Meeting
Lucent Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Balance Sheet
Lucent Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 100660768 was registered on 02 Dec 2022.
- Charges
A charge with State Bank Of India of Rs. 16.10 Cr registered on 28 Mar 2018 with Charge ID 100173302 was modified on 16 Nov 2022.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100640164 was registered on 21 Oct 2022.
Frequently asked questions
What is the Incorporation or founding date of Lucent Drugs Private Limited?
Lucent Drugs Private Limited was incorporated on 02 Aug 2017.
What is authorized share capital and paid-up capital of Lucent Drugs Private Limited?
The authorized share capital of Lucent Drugs Private Limited is ₹ 9.00 Cr and paid-up capital is ₹ 6.28 Cr.
Who are the current board members & directors of Lucent Drugs Private Limited?
Currently 2 directors are associated with Lucent Drugs Private Limited.
- Sreenivasulu Devarasetty
- Mahaveer Chand Jain
What is the registered address of Lucent Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lucent Drugs Private Limited is Flat No.W-109 Svss Nivas Oppo.Gokul Theatre Czech Colony, Street No.1 India, Sanathnagar, Telangana, 500018.
What is the corporate identification number (CIN) and company number of Lucent Drugs Private Limited?
The corporate identification number (CIN) of Lucent Drugs Private Limited is U24100TG2017PTC118662 and the company number is 118662 as per Ministry of Corporate Affairs (MCA).
What is the official website of Lucent Drugs Private Limited?
The Official website of Lucent Drugs Private Limited is https://www.lucentdrugs.com
What has been the recent revenue trend for Lucent Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Lucent Drugs Private Limited has fallen by -8.35%.
How many employees does Lucent Drugs Private Limited currently have?
As Per 2023 financial reports, 63 employees are currently employed by Lucent Drugs Private Limited.
What change has been observed in the net worth of Lucent Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Lucent Drugs Private Limited has experienced an upsurge of 52.01%.
What are the total open charges for Lucent Drugs Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Lucent Drugs Private Limited amount to ₹ 35.44 Cr.
When was the last Balance Sheet of Lucent Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Lucent Drugs Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
VJ
Vinod JainManaging DirectorSD
Sai DevarasettyDirector